Table 2.
Tests for statistical differences between characteristics of identified peptides.
| Group 1 | Group2 | p-value |
|---|---|---|
| Peptide length | ||
| Non-spliced products | Non-spliced synthesis artifacts | <2e-16 |
| Non-spliced products | Non-spliced random control | <2e-16 |
| Non-spliced synthesis artifacts | Non-spliced random control | <2e-16 |
| cis spliced products | cis spliced synthesis artifacts | <2e-16 |
| cis spliced products | cis spliced random control | <2e-16 |
| cis spliced synthesis artifacts | cis spliced random control | <2e-16 |
| trans spliced products | trans spliced synthesis artifacts | <2e-16 |
| trans spliced products | trans spliced random control | <2e-16 |
| trans spliced synthesis artifacts | trans spliced random control | <2e-16 |
| Non-spliced products | cis spliced products | <2e-16 |
| cis spliced products | trans spliced products | <2e-16 |
| Non-spliced products | trans spliced products | <2e-16 |
| Splice-reactant length: SR1 | ||
| Normal cis spliced products | Normal cis spliced synthesis artifacts | <2e-16 |
| Normal cis spliced products | Normal cis spliced random control | <2e-16 |
| Normal cis spliced synthesis artifacts | Normal cis spliced random control | <2e-16 |
| Reverse cis spliced products | Reverse cis spliced synthesis artifacts | <2e-16 |
| Reverse cis spliced products | Reverse cis spliced random control | 6.3e-16 |
| Reverse cis spliced synthesis artifacts | Reverse cis spliced random control | 7.9e-13 |
| trans spliced products | trans spliced synthesis artifacts | <2e-16 |
| trans spliced products | trans spliced random control | <2e-16 |
| trans spliced synthesis artifacts | trans spliced random control | 1.8e-11 |
| Splice-reactant length: SR2 | ||
| Normal cis spliced products | Normal cis spliced synthesis artifacts | <2e-16 |
| Normal cis spliced products | Normal cis spliced random control | 0.055 |
| Normal cis spliced synthesis artifacts | Normal cis spliced random control | <2e-16 |
| Reverse cis spliced products | Reverse cis spliced synthesis artifacts | <2e-16 |
| Reverse cis spliced products | Reverse cis spliced random control | <2e-16 |
| Reverse cis spliced synthesis artifacts | Reverse cis spliced random control | <2e-16 |
| trans spliced products | trans spliced synthesis artifacts | <2e-16 |
| trans spliced products | trans spliced random control | <2e-16 |
| trans spliced synthesis artifacts | trans spliced random control | <2e-16 |
| Intervening sequence length | ||
| Normal cis spliced products | Normal cis spliced synthesis artifacts | 0.013 |
| Normal cis spliced products | Normal cis spliced random control | <2e-16 |
| Normal cis spliced synthesis artifacts | Normal cis spliced random control | <2e-16 |
| Reverse cis spliced products | Reverse cis spliced synthesis artifacts | 0.042 |
| Reverse cis spliced products | Reverse cis spliced random control | 0.014 |
| Reverse cis spliced synthesis artifacts | Reverse cis spliced random control | 0.14 |
Group 1 is compared to group 2 using Kolmogorov-Smirnov test. Resulting p-values are listed.